imatinib mesylate has been researched along with Cutaneous Fistula in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Jiromaru, R; Matsuo, M; Nakagawa, T | 1 |
| Chan, WY; Chung, SC; Mok, TS; Ng, EK; Wong, SK | 1 |
2 other study(ies) available for imatinib mesylate and Cutaneous Fistula
| Article | Year |
|---|---|
Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report.
Topics: Aged; Cutaneous Fistula; Humans; Imatinib Mesylate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Molecular Targeted Therapy; Pharyngeal Diseases; Postoperative Complications; Receptors, Platelet-Derived Growth Factor; Retrospective Studies; Vascular Endothelial Growth Factor A | 2022 |
Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor.
Topics: Benzamides; Cutaneous Fistula; Gastric Fistula; Humans; Imatinib Mesylate; Laparotomy; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Postoperative Complications; Pyrazoles; Pyrimidines; Stomach Neoplasms; Tomography, X-Ray Computed | 2003 |